Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.

Okamoto, Masahiro

Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy. [electronic resource] - Ophthalmic surgery, lasers & imaging retina Jan 2015 - 25-32 p. digital

Publication Type: Comparative Study; Journal Article

2325-8179

10.3928/23258160-20150101-04 doi


Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Bevacizumab
Blood Flow Velocity
Blood Pressure--physiology
Central Serous Chorioretinopathy--diagnosis
Choroid--physiopathology
Chronic Disease
Coloring Agents
Female
Fluorescein Angiography
Heart Rate
Humans
Indocyanine Green
Intraocular Pressure--physiology
Intravitreal Injections
Laser-Doppler Flowmetry
Male
Middle Aged
Organ Size
Prospective Studies
Regional Blood Flow
Retina--pathology
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Visual Acuity--physiology